BioDelivera
YC F26San Francisco, US · Founded 2025 · 2 employees · 1 known investors
Find your way into BioDelivera
Sign up to see every warm intro you have to BioDelivera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioDelivera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioDelivera is developing GCV™, a drug delivery platform that targets diseased cells while leaving healthy ones intact and can carry genetic medicines, DNA, RNA, small molecules, or combinations of them. The company has shown results in tumors, muscle, and brain tissue, serving the therapeutics and genetic medicine sector.
Founders & leadership· Y Combinator alumni (F26)
IT

Investors · 1
In the news
Frequently asked questions
- What does BioDelivera do?
- BioDelivera is developing GCV™, a drug delivery platform that targets diseased cells while leaving healthy ones intact and can carry genetic medicines, DNA, RNA, small molecules, or combinations of them. The company has shown results in tumors, muscle, and brain tissue, serving the therapeutics and genetic medicine sector.
- Who are BioDelivera's investors?
- BioDelivera's investors include Y Combinator.
- Where is BioDelivera headquartered?
- BioDelivera is headquartered in San Francisco, US.


